Skip to main content

04.08.2016 | Original Paper | Ausgabe 1/2017

Journal of Natural Medicines 1/2017

The action and mechanism of myrislignan on A549 cells in vitro and in vivo

Journal of Natural Medicines > Ausgabe 1/2017
XinGang Lu, Liu Yang, JingXian Chen, JiAn Zhou, XiaoDan Tang, YingGang Zhu, HongFu Qiu, Jie Shen
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s11418-016-1029-6) contains supplementary material, which is available to authorized users.
X. Lu and L. Yang contributed to this work equally.


Myrislignan is a natural compound with little pharmacological study. In our investigation, we investigated the effect of myrislignan in the induction of apoptosis in A549 cells in vitro and in vivo. Myrislignan inhibited the proliferation of A549 cells in a dose- and time-dependent manner assayed by MTT. In addition, Hoechst flow cytometry showed that myrislignan significantly induced apoptosis and cell cycle arrest in A549 cells. The apoptosis and anti-cell proliferation was mediated by the activation of mitogen-activated protein kinase and the inhibition of epidermal growth factor receptor signal pathway, change of mitochondrial membrane potential, the releasing of c-Myc, the downregulation of the level of the anti-apoptotic protein Bcl-2, and the upregulation of the level of the pro-apoptotic protein Bax. In conclusion, those results reveal a potential mechanism for the anti-cancer effect of myrislignan on human lung cancer, while suggesting that myrislignan may be a promising compound for the treatment of lung cancer.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Jetzt e.Med bestellen und 100 € sparen!

Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

Journal of Natural Medicines 1/2017 Zur Ausgabe